Aggravation of ovalbumin-induced murine asthma by co-exposure to desert-dust and organic chemicals: an animal model study. by Ren, Yahao et al.
UC Davis
UC Davis Previously Published Works
Title
Aggravation of ovalbumin-induced murine asthma by co-exposure to desert-dust and 
organic chemicals: an animal model study.
Permalink
https://escholarship.org/uc/item/9gq9q27j
Journal
Environmental health : a global access science source, 13(1)
ISSN
1476-069X
Authors
Ren, Yahao
Ichinose, Takamichi
He, Miao
et al.
Publication Date
2014
DOI
10.1186/1476-069x-13-83
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Ren et al. Environmental Health 2014, 13:83
http://www.ehjournal.net/content/13/1/83RESEARCH Open AccessAggravation of ovalbumin-induced murine
asthma by co-exposure to desert-dust and
organic chemicals: an animal model study
Yahao Ren1, Takamichi Ichinose2*, Miao He3, Keiichi Arashidani4, Yasuhiro Yoshida4, Seiichi Yoshida2,
Masataka Nishikawa5, Hirohisa Takano6, Guifan Sun3* and Takayuki Shibamoto7Abstract
Background: The organic chemicals present in Asian sand dust (ASD) might contribute to the aggravation of lung
eosinophila. Therefore, the aggravating effects of the Tar fraction from ASD on ovalbumin (OVA)-induced lung
eosinophilia were investigated.
Methods: The Tar fraction was extracted from ASD collected from the atmosphere in Fukuoka, Japan. ASD
collected from the Gobi desert was heated at 360°C to inactivate toxic organic substances (H-ASD). ICR mice were
instilled intratracheally with 12 different test samples prepared with Tar (1 μg and 5 μg), H-ASD, and OVA in a
normal saline solution containing 0.02% Tween 80. The lung pathology, cytological profiles in the bronchoalveolar
lavage fluid (BALF), inflammatory cytokines/chemokines in BALF and OVA-specific immunoglobulin in serum were
investigated.
Results: Several kinds of polycyclic aromatic hydrocarbons (PAHs) were detected in the Tar sample. H-ASD + Tar
5 μg induced slight neutrophilic lung inflammation. In the presence of OVA, Tar 5 μg increased the level of
eosinophils slightly and induced trace levels of Th2 cytokines IL-5 and IL-13 in BALF. Also mild to moderate goblet
cell proliferation and mild infiltration of eosinophils in the submucosa of airway were observed. These pathological
changes caused by H-ASD + OVA were relatively small. However, in the presence of OVA and H-ASD, Tar, at as low
a level as 1 μg, induced severe eosinophil infiltration and proliferation of goblet cells in the airways and significantly
increased Th2 cytokines IL-5 and IL-13 in BALF. The mixture showed an adjuvant effect on OVA-specific IgG1
production.
Conclusions: These results indicate that H-ASD with even low levels of Tar exacerbates OVA-induced lung
eosinophilia via increases of Th2-mediated cytokines. These results suggest that ASD-bound PAHs might contribute
to the aggravation of lung eosinophila.
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Ambient particulate matter (PM)2.5 (particle sizes less
than 2.5 μm) and PM10 (particle sizes of 2.5 μm ~10 μm)
are positively related to an exacerbation of respiratory dis-
eases like asthma and chronic bronchitis [1,2]. The health
issue by desert-dust (—well known as PM10—) has arisen
all over the world [3-6]. Asian sand dust (ASD) storms
arise annually from the Gobi Desert, the Taklimakan des-
ert, and loess areas of interior China during the spring
season and/or sometimes during the autumn season every
year. When a large scale sandstorm occurs from these
deserts, ASD aerosol spreads over large areas, including
East China, the Korean Peninsula and Japan as well as
crossing the North Pacific to the United States [7-9].
Some reports suggest that ASD events are associated
with increased respiratory symptoms in both adults and
children with asthma [6,10,11]. Similar to these epidemio-
logical investigations, our previous studies showed an
aggravating effect of ASD on ovalbumin (OVA)-induced
lung eosinophilia in a murine model of asthma. On the
other hand, if ASD is heated (H-ASD) at 360°C to inacti-
vate microbial materials and chemicals, it caused fewer ef-
fects [12,13]. On the basis of these results, we
hypothesized that the organic substances and chemicals
adhering to ASD contribute to the aggravation of lung
eosinophila. Recently, we showed that ASD contaminated
with a trace level of bacterial lipopolysaccharide (LPS)
aggravated murine lung eosinophilia [14].
By-products, such as organic chemical, sulfates (SO4
2−)
and nitrates (NO3
−), formed from the combustion of coal
and other fossil fuels in industrialized Eastern Asia adhere
to ASD during long-range transportation of the dust
[15-17]. PM2.5, such as diesel exhaust particles (DEP), is
present in the Tar fraction, which contains polycyclic
aromatic hydrocarbons (PAHs). Previous studies have
reported that Tar fraction extracted from DEP containing
PAHs exacerbated OVA-induced experimental asthma
[18,19]. Therefore, it should be ascertained whether Tar
fractions extracted from ASD are related to the aggrava-
tion of lung eosinophilia by ASD.
In the present study, the exacerbating effects of Tar
and/or H-ASD on OVA- induced lung eosinophilia were
investigated using ICR mice.
Methods
Animals
Specific pathogen-free male ICR mice (6 weeks of age)
were obtained from Charles River Japan, Inc. (Kanagawa,
Japan). The mice were observed for 1 week to measure
body weight and to eliminate those who showed signs of
infection. The mice used in the study were 7 weeks of
age. CE-2 commercial diet (CLEA Japan, Tokyo, Japan)
and water were given ad libitum. The mice were housed
in plastic cages lined with soft wood chips. The cageswere placed in a conventional room, which was air con-
ditioned at 23°C with a light/dark (12 h/12 h) cycle, and
humidity ranging from 55 to 70%. The study adhered to
the US National Institutes of Health guidelines for the
use of experimental animals. The animal care method
was also approved by the animal care and use committee
at Oita University of Nursing and Health Sciences in
Oita, Japan.
Sample preparations and analysis of Tar components
ASD collected from surface soils in the Gobi desert was
purified for use as the standard in the present study.
The size distribution peak was observed at 3.9 μm. The
chemical elements in ASD were as reported previously:
51.6% SiO2, 14.3% Al2O3, 5.5% Fe2O3, 1.3% Na2O, 9.6%
CaCO3, 0.6% CaO, 2.5% MgO, 0.7% TiO2 and 2.6% K2O.
And, as in the previous study, 11.3% of total oxides were
lost at ig [14,20]. PAHs were not detected in the stand-
ard ASD. A portion of the standard ASD was heated at
360°C for 30 min in an electric heater to inactivate toxic
materials (sulfate, nitrate, microorganism, etc.). These
samples are termed H-ASD in the present study.
The ASD that was the focus of this study was
collected from the atmosphere at the University of
Occupational and Environmental Health, Kitakyushu,
Fukuoka, Japan on November 13–15, 2010—during a
massive dust storm event in East Asia—using a high-
volume air sampler (Sibata Scientific Technology, Japan)
equipped with a quartz-filter (20 × 25 cm, 2500QAT-
UP, Tokyo Dylec Corp, Japan). After the ASD was
trapped on a quartz filter, the quartz filter (20 × 25 cm,
2500QAT-UP, Tokyo Dylec Corp, Japan) was cut into
1/8 piece. The pieces of cut filter were extracted twice
with a 20 mL portion of dichloromethane (Wako Pure
Chemicals, Industries Ltd, Japan) for 15 min at 15°C by
ultrasonic extraction. The extract was filtered with an
NO 5C filter paper and the filtrate allowed to stand in
the dark until the solvent was evaporated to dryness to
yield solid materials. Tar 13.4 mg (3.35% w/w) was
obtained from 400 mg of ASD.
The residual materials were dissolved in 0.5 mL aceto-
nitrile then analyzed for PAHs by a Hitachi Model 600
HPLC (Hitachi, Japan) equipped with a Model L-7485
fluorescence detector (Hitachi, Japan) and a 4.0 mmφ ×
250 mm column packed with Wakosil-II 5C 18HG
(Waka Pure Chemicals Industry, Ltd., Japan). The mobile
phase was acetonitrile/water (80/20, v/v) at 1.5 ml/min.
Identification of PAHs in the sample was conducted
by comparison of the HPLC retention time and fluores-
cence/excitation spectra to those of authentic PAHs
according to a previously reported method [21]. Authen-
tic PAHs were obtained from Supelco (Bellefonte, PA,
USA), Aldrich Chemical Co., Inc (Milwaukee, WI, USA)
and Tridom Chemical Inc (Hauppauge, NY, USA).
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ICR mice (n = 168) were divided into 12 groups (n = 14
per group) and each group was treated with a specific
testing sample. The 12 test samples were composed of a
0.1 mL basic saline solution (0.9% NaCl and 0.02%
Tween 80) and the various testing materials shown in
Table 1.
The instillation dose of H-ASD was 0.1 mg per mouse
[14]. Airborne ASD contains about 1% - 5% tar. Therefore,
the instillation doses of Tar were set to 1 μg and 5 μg per
0.1 mg ASD, to be consistent with the proportion of Tar to
ASD generally. The mice were intratracheally challenged
with each sample 4 times at 2-week intervals. One day after
the last intratracheal administration, mice from all groups
were euthanized by exsanguination under deep anesthesia
by intraperitoneal injection of pentobarbital. Serum was
taken by centrifugal separation of blood. The serum sam-
ples were stored at −80°C until analysis for OVA-specific
immunoglobulin E (IgE) and IgG1 antibodies.
Bronchoalveolar lavage fluid (BALF)
Eight out of the 14 mice in each group were examined for
the free cell contents in BALF using a previously reported
method [22,23]. Briefly, the lungs were lavaged twice with
an injection of sterile saline solution (0.8 ml) at 37°C. After
the fluids from the two lavages were combined and cooled
to 4°C, the resultant solution was centrifuged at 1500 rpm
for 10 min. The total cell count of the fresh fluid speimen
was determined by a hemocytometer. Differential cell
counts were assessed on cytological preparations. Slides
were prepared using a Cytospin (Sakura Co., Ltd, Tokyo,
Japan) and stained with Diff-Quik (International Reagents
Co., Kobe, Japan) to identify the eosinophils with red
granules. A total of 300 cells were counted under micro-
scopic examination. The BALF supernatants were stored
at −80°C until analysis for cytokines and chemokines.Table 1 Amounts of Tar, H-ASD and OVA contained in
each sample
Sample Tar H-ASD OVA
Control 0 0 0
Tar 1 1 μg 0 0
Tar 5 5 μg 0 0
H-ASD 0 0.1 mg 0
H-ASD + Tar 1 1 μg 0.1 mg 0
H-ASD + Tar 5 5 μg 0.1 mg 0
OVA 0 0 1 μg
OVA + Tar 1 1 μg 0 1 μg
OVA + Tar 5 5 μg 0 1 μg
OVA + H-ASD 0 0.1 mg 1 μg
OVA + H-ASD + Tar 1 1 μg 0.1 mg 1 μg
OVA + H-ASD + Tar 5 5 μg 0.1 mg 1 μgPathological evaluation
The remaining 6 mice in each group were used for
pathological examination. The lungs were fixed by a
10% neutral phosphate-buffered formalin solution. After
separation of the lobes, 2-mm-thick blocks were taken
for paraffin embedding. Embedded blocks were sectioned
at a thickness of 3 μm and then stained with hematoxylin
and eosin (H & E) to evaluate the degree of infiltration of
eosinophils and lymphocytes in the airway from proximal
to distal. The sections were stained with periodic acid-
Schiff (PAS) to evaluate the degree of proliferation of
goblet cells in the bronchial epithelium. A pathological
analysis of inflammatory cells and epithelial cells in the
airway was performed using a Nikon ECLIPSE light
microscope (Nikon Co., Tokyo, Japan). The degree of in-
filtration of eosinophils and lymphocytes in the airway or
proliferation of goblet cells in the bronchial epithelium
was graded in blinded fashion as: 0, not present; 1, slight;
2, mild; 3, moderate; 4, moderate to marked; 5, marked.
‘Slight’ was defined as less than 20% of the airway with
eosinophilic inflammatory reaction or with goblet cells
stained with PAS; ‘mild’ as 21 - 40%; ‘moderate’ as 41 -
60%; ‘moderate to marked’ as 61 - 80%; and marked as
more than 80% of the airway [22,23].
Quantitation of cytokines and chemokines in BALF
The cytokine and chemokine protein levels were deter-
mined by enzyme-linked immunosorbent assays (ELISA).
IL-5 and IL-12 were measured using an ELISA kit from
Endogen, Inc. (Cambridge, MA, USA). MCP-3 was mea-
sured using an ELISA kit from Bender MedSystems Inc.
(Burlingame, CA, USA). IL-1β, IL-4, IL-6, IL-13, IFN-γ,
KC, TGF-β, Eotaxin, MCP-1, MIP-1α, RANTES were
measured using an ELISA kit from R&D Systems Inc.
(Minneapolis, MN, USA).
OVA-specific IgE and IgG1 antibodies
OVA-specific IgE and IgG1 antibodies in serum were
measured using the Mouse OVA-IgE ELISA kit and
Mouse OVA-IgG1 ELISA kit (Shibayagi Co., Shibukawa,
Japan). According to the manufacturer’s protocol, 1U of
the anti-OVA IgE is defined as 1.3 ng of the antibody;
and 1U of the anti-OVA IgG1 is defined as 160 ng of the
antibody. The absorption of 450 nm (sub-wave length,
620 nm) for OVA-specific IgE and IgG1 antibody was
measured by a microplate reader (Spectrafluor, Tecan,
Salzburg, Austria).
Statistical analysis
Statistical analysis of pathological evaluation in the air-
way, cell numbers (macrophages, neutrophils, eosinophils
and lymphocytes), cytokines, and chemokine proteins in
BALF was conducted using the Tukey Test for Pairwise
Comparisons, All the analyses were performed with IBM
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Differences were considered significant at p <0.05.Results
Concentration of PAHs in Tar from ASD
PAHs detected in the Tar are shown in descending order
of ppm level in Table 2. The concentration of fluoranthene
(217 μg/g) was the highest, followed by benzo[e]pyrene
(174 μg/g), and indeno[1,2,3-cd]pyrene (122 μg/g). Con-
centration of the most potent carcinogen, benzo[a]pyrene,
was 34.6 μg/g.The cell numbers in BALF from mice treated by OVA,
H-ASD and Tar
Figure 1 shows the cellular profiles in BALF. Tar 1 and
Tar 5 increased the number of macrophages by 63% and
50%, respectively compared with the control. The addition
of H-ASD to Tar 1 and Tar 5 increased neutrophils and
lymphocytes slightly compared with the control. The
addition of OVA to Tar 1 and Tar 5 increased eosinophils
slightly, and they also make significant increases in macro-
phages and neutrophils (OVA +Tar 5 group) compared
with the non-OVA treated groups. When Tar 1 was added
to H-ASD+OVA, eosinophil number increased signifi-
cantly compared with the OVA alone group.Pathological changes in the airways of mice treated by
OVA, H-ASD and Tar
Figure 2 shows the pathological changes caused by the
testing samples in the murine airway.Table 2 Concentrations of PAHs in Tar
PAH Concentration (μg/g)
Fluoranthene 217
Benzo[e]pyrene 174
Indeno[1,2,3-cd]pyrene 122
Benzo[j]fluoranthene 92.2
Pyrene 73.1
Coronene 64.1
Benz[a]anthracene 60.1
Chrysene 54.8
Benzo[ghi]perylene 52.1
Dibenzo[a,h]anthracene 43.3
Benzo[a]pyrene 34.6
Benzo[k]fluoranthene 27.3
Benzo[b]fluoranthene 20.8
Perylene 9.12
Tar fraction extracted from ASD were analyzed for PAHs by a HPLC equipped
with a fluorescence detector and a 4.0mmφ × 250 mm column a packed with
Wakosil-II 5C 18HG.When OVA + Tar 5 samples were used for exposures,
mild to moderate increases of eosinophils, lymphocytes
and goblet cells occurred compared with OVA exposures
alone. OVA +H-ASD caused a slight to mild increases
of these cells compared with OVA alone. However, when
Tar 1 or Tar 5 was added to H-ASD +OVA samples,
moderate to marked increase of these cells compared
with H-ASD +OVA was observed.
Figures 3 and 4 illustrate the effects of Tar on patho-
logical changes in the lungs. No pathological alterations
were found in the lungs of the control and Tar 1
(Figure 4A and B). H-ASD, H-ASD +Tar 1 and H-ASD +
Tar 5 caused slight infiltration of inflammatory cells in the
submucosa of the airway (data not shown).
Compared with the control group (Figures 3A; 4A),
OVA alone caused a very slight proliferation of goblet
cells in the airway epithelium (Figure 3D) as well as of
eosinophils, neutrophils and lymphocytes in the sub-
mucosa of airway (Figure 4D). OVA + Tar 5 caused
mild to moderate goblet cell proliferation (Figure 3F)
and mild infiltration of eosinophils in the submucosa
of airway (Figure 4F) compared with the group of OVA
alone (Figure 3D; Figure 4D).
H-ASD +OVA also caused a slight goblet cell prolifera-
tion and slight infiltration of eosinophils and lympho-
cytes in the submucosa of airway (Figures 3G; 4G)
compared with OVA alone (Figures 3D, 4D). However,
H-ASD +OVA + Tar 1 and H-ASD +OVA + Tar 5 caused
moderate goblet cell proliferation in the airway epithe-
lium (Figure 3H, I) and moderate to marked accumula-
tion of eosinophils, neutrophils and lymphocytes in the
submucosa of airways (Figure 4H, I) compared with OVA
alone (Figures 3D, 4D). These pathological alterations in
the H-ASD +OVA + Tar 1 group were more severe than
in the H-ASD +OVA + Tar 5 group.
Protein levels of cytokines and chemokines in BALF from
mice treated by OVA, H-ASD and Tar
Figure 5 shows the levels of IL-12, KC, MIP-1α and
RANTES in BALF. Tar 1 and Tar 5 did not increase the
proteins examined, whereas H-ASD significantly increased
the protein level of MIP-1α and KC, and H-ASD +Tar
increased all proteins compared with the control group.
The addition of Tar to OVA showed a dose-dependent
increase in all proteins. However, when Tar was added to
an H-ASD+OVA sample, all proteins did not show a
dose-dependent increase; the mice treated by H-ASD +
OVA+Tar 1 contained higher protein levels of KC,
MIP-1α and RANTES.
Figure 6 shows the expression of IL-1β, IL-6, MCP-1
and MCP-3. H-ASD and H-ASD + Tar increased the
protein level of MCP-1 slightly compared with the con-
trol group. The addition of Tar to H-ASD + OVA
increased all proteins considerably, and the mice
Figure 1 Cellular profile in bronchoalveolar lavage fluids (BALF). All values are expressed as mean ± SE. *p < 0.05 vs. control; †p < 0.05 vs.
Tar 1; ‡p < 0.05 vs. Tar 5; §p < 0.05 vs. H-ASD; &p < 0.05 vs. H-ASD + Tar 1; #p < 0.05 vs. H-ASD + Tar 5; ¶p < 0.05 vs. OVA; αp < 0.05 vs. OVA + Tar 5.
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levels of all proteins compared with the H-ASD +
OVA + Tar 5 group.
Figure 7 shows the expression of IL-4, IL-5, IL-13
and eotaxin in BALF. These proteins are known asFigure 2 Evaluation of pathological changes in the murine airway. Th
(0) none; (1) slight; (2) mild; (3) moderate; (4) moderate to marked; (5) mark
were conducted using the Tukey Test for Pairwise Comparisons. *p < 0.05 v
&p < 0.05 vs. H-ASD + Tar 1; #p < 0.05 vs. H-ASD + Tar 5; ¶p < 0.05 vs. OVA; αpallergy associated mediators. There was a slight in-
crease in levels of IL-5 in the samples treated by OVA
alone. The addition of Tar 5 to OVA increased IL-13
and eotaxin slightly and caused a further, slight in-
crease of IL-5. Addition of H-ASD to OVA increasede degree of pathological changes in the airway was estimated as:
ed. All values are expressed as mean ± SE (n = 6). Statistical analyses
s. control; †p < 0.05 vs. Tar 1; ‡p < 0.05 vs. Tar 5; §p < 0.05 vs. H-ASD;
< 0.05 vs. OVA + Tar 1; βp < 0.05 vs. H-ASD + OVA.
A B C
D E F
G H I
Tar 1 μg Tar 5 μg
OVA
OVA
+
H-ASD
Tar 0 μg
Saline
Figure 3 Effects of test samples on pathological changes in the lungs. (A) Control, (B) Tar 1: no pathologic alterations were seen in the
lungs. (C) Tar 5: very slight infiltration of inflammatory cells in the airway submucosa. Goblet cells were not seen. (D) OVA alone: slight
proliferation of goblet cells in the airway epithelium and very slight infiltration of inflammatory cells into the airway submucosa. (E) OVA + Tar 1:
goblet cell proliferation was somewhat stronger than in the samples treated with OVA alone (D). (F) OVA + Tar 5: mild proliferation of goblet
cells in the airway epithelium, and infiltration of inflammatory cells into the airway submucosa. (G) H-ASD + OVA: mild goblet cell proliferation
and mild infiltration of inflammatory cells into the airway submucosa. (H) H-ASD + OVA + Tar 1: moderate goblet cell proliferation, severe
infiltration of inflammatory cells into the airway submucosa. (I) H-ASD + OVA + Tar 5: mild to moderate goblet cell proliferation, moderate
infiltration of inflammatory cells into the airway submucosa. (A–I) PAS stain; bar = 50 μm.
G H I
A B C
E FD
gμ5raTgμ1raT
OVA
OVA
+
H-ASD
Tar 0 μg
Saline
Figure 4 Effects of test samples on infiltration of inflammatory cells in the airway. (A) Control, (B) Tar 1, (C) Tar 5: no pathological changes
in lungs treated with saline, Tar 1 and Tar 5. (D) OVA alone: slight infiltration of eosinophils, neutrophils and lymphocytes into the airway
submucosa. (E) OVA + Tar 1, (F) OVA + Tar 5, (G) H-ASD + OVA: slight to mild infiltration of inflammatory cells into the airway submucosa.
(H) H-ASD + OVA + Tar 1: marked accumulation of eosinophils, neutrophils and lymphocytes in the airway submucosa. (I) H-ASD + OVA + Tar 5:
moderate infiltration of these inflammatory cells into the submucosa of airways. (A–I) HE stain; bar = 20 μm.
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Figure 5 Expressions of IL-12, KC, MIP-1α and RANTES in BALF. All values are expressed as mean ± SE (n =8). *p < 0.05 vs. control; †p < 0.05
vs. Tar 1; ‡p < 0.05 vs. Tar 5; §p < 0.05 vs. H-ASD; &p < 0.05 vs. H-ASD + Tar 1; #p < 0.05 vs. H-ASD + Tar 5; p < 0.05 vs. OVA; αp < 0.05 vs. OVA + Tar 1;
βp < 0.05 vs. H-ASD + OVA.
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ASD + OVA triggered a remarkable increase in all pro-
teins compared with the other OVA-treated groups.
TGF-β and IFN-γ were not detected in the present
study.Figure 6 Expressions of IL-1β, IL-6, MCP-1 and MCP-3 in BALF. All valu
Tar 5; ‡p < 0.05 vs. H-ASD + Tar 1; §p < 0.05 vs. OVA; &p < 0.05 vs. OVA + TarEnhancement of OVA-specific IgG1 by H-ASD and Tar
Figure 8 shows the effects of test samples on IgG1 produc-
tion in serum. IgG1 was not detected in the samples of the
control, Tar 1, Tar 5, H-ASD, H-ASD+ Tar 1 or H-ASD +
Tar 5 samples. The mice treated by H-ASD+OVA+Tar 1es are expressed as mean ± SE (n =8). *p < 0.05 vs. control; †p < 0.05 vs.
1; #p < 0.05 vs. H-ASD + OVA; p < 0.05 vs. H-ASD + OVA + Tar 1.
Figure 7 Expressions of IL-4, IL-5, IL-13 and eotaxin in BALF. All values are expressed as mean ± SE (n = 8). *p < 0.05 vs. control; †p < 0.05 vs.
Tar 1; ‡p < 0.05 vs. H-ASD + Tar 1; §p < 0.05 vs. OVA; &p < 0.05 vs. OVA + Tar 1; #p < 0.05 vs. H-ASD + OVA.
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treated by H-ASD +OVA+Tar 5. In the present study,
OVA-specific IgE was not detected.
Discussion
It is possible that desert dust-bound organic chemicals
contribute to the aggravation of allergic lung inflamma-
tion. The present study demonstrated that Tar adhering
to ASD contributed to the aggravating effect on OVA-Figure 8 Effects of test samples on OVA-specific IgG1 production
in serum. According to the manufacturer’s protocol, 1 U of the
anti-OVA IgG1 is defined as 160 ng of the antibody. All values are
expressed as mean ± SE. *p < 0.05 vs. control; †p < 0.05 vs. H-ASD +
Tar 1; ‡p < 0.05 vs. H-ASD + Tar 5.induced lung eosinophilia. The Tar used in the present
study contained high concentration of PAHs, suggesting
that the aggravating effect by Tar greatly due to PAHs.
However, the effects of pro-inflammatory mediators and
lung pathology in the H-ASD +OVA + Tar 5 group were
reduced.
It has been reported that aryl hydrocarbon receptor
(AhR), which is the receptor for PAHs, activated by
highest affinity ligand 2,3,7,8-tetrachlodibenzo-p-dioxin
(TCDD) decreased pro-inflammatory cytokines levels
and induce the Fox3+ Treg cell [24]. LPS-induced
production of pro-inflammatory cytokines is augmented
in AhR−/− peritoneal macrophages compared with WT
cells [25]. Hence, the high dose of Tar might cause the
immune suppressive effect by the activation of AhR.
Eosinophilia makes an important contribution to the
pathophysiology and pathology of allergic asthma [26].
IL-5 has been recognized as the major maturation, differ-
entiation and recruitment factor for eosinophils [27,28].
IL-13 is another important factor; in a mouse model of
airway effects due to asthma, eosinophilia was markedly
inhibited by neutralization of IL-13 [29]. Moreover, IL-13
is known to induce goblet cell proliferation [30] and is a
characteristic feature of allergic asthma [31]. In addition,
Eotaxin and MCP-3 were also known to be effective
eosinophil chemoattractants [32,33], while the toxic
mediators, such as major basic proteins, reactive oxygen
radicals, platelet-activating factors, and leukotrienes
released from eosinophils, play an important role in in-
ducing bronchial mucosal injury [34]. Therefore, it is not
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eosinophil-relevant chemokines, including Eotaxin and
MCP-3, aggravated eosinophilic lung inflammation in the
present study. The major basic protein released from
eosinophils is known to activate neutrophils and subse-
quently cause them to release superoxide [35]. On the
other hand, the increases of RANTES and MCP-1 may
also contribute to the neutrophilia and exacerbation of
airway inflammation [36,37], so it is possible that the
airway injury observed in the present study may be the
result of the toxic mediators released from eosinophils
and neutrophils.
A case control study has shown that exposure to PAHs
originating from combustion of organic matters, espe-
cially phenanthrene, is associated with childhood asthma
and oxidative stress [38]. Several in vitro studies have
shown that PAHs benzo[a]pyrene, 1, 6-BaP-quinone
(BPQ), and 3, 6-BPQ in incubation with human basophils
enhanced histamine release and IL-4 production in re-
sponse to crosslinking the high-affinity IgE receptor, Fc
epsilon RI, and caused a significant increase of reactive
oxygen species (ROS) [39]. β-Napthoflavone, a represen-
tative PAH, and the quinone metabolites induced Jun
kinase and p38 mitogen-activated protein kinase (MAPK)
activities and the generation of activator protein-1 (AP-1)
in RAW264.7 macrophage cell lines. Activation of MAPK
was dependent on generation of oxidative stress [40].
Pyrene, another representative PAH in diesel exhaust,
increased IL-8 promoter activity, mRNA production and
protein expression in human epithelium cells. AP-1 and
nuclear factor-κB (NF-κB) binding sites in the IL-8 pro-
moter regulated IL-8 production [41]. The high level of
oxidative stress caused by PAHs activated the NF-κB and
MAPKs signaling cascades, which are important for the
expression of many genes that participate in pulmonary
inflammation [42]. These genes include IL-4, IL-5, IL-10,
IL-13, IL-8, RANTES, MIP-1α, MCP-3, GM-CSF, TNF-α,
ICAM-1 and VCAM-1 [43]. It is interesting that Tars 1
and 5, in particular Tar 1, markedly enhanced Th2 re-
sponses in the presence of OVA and H-ASD, although
Tar showed weak Th2 response in the presence of OVA.
It is clear that H-ASD has potential to elicit a weak
reaction by Tar and OVA. Three mixtures increased IL-4,
IL-5, IL-13, RANTES, KC, MIP-1α, and MCP-3. H-ASD
might help generation of ROS by PAHs, which present in
the Tar used in the present study (Table 2). Therefore, we
speculate that the aggravating effect is due to the
enhancement of inflammatory mediators via oxidative
stress caused by the combination of H-ASD and PAHs in
Tar.
On the other hand, in the presence of H-ASD and
OVA, Tars 1 and 5 caused the production of OVA-
specific IgG1 in serum. It seems that an increase of IgG1
is being interlocked with activation of Th2 responsecaused by these mixtures. Diesel samples with different
levels of PAHs aggravated OVA-induced airway inflam-
mation along with elevated OVA-specific IgG1 [19].
Antigen-specific IgG1 can cause degranulation via an Fcγ
RII receptor on the eosinophil’s surface [44]. Therefore,
antibodies may play an important role in the aggravation
of lung eosinophilia caused by H-ASD +OVA + Tar.
Conclusions
This study demonstrates that H-ASD with low levels of
Tar exacerbates OVA-induced lung eosinophilia via in-
creases in Th2-mediated cytokines and antigen-specific
immunoglobulin. The aggravation of the allergic lung
inflammation by Tar might be caused by PAHs. Future
studies should investigate the mechanism of how ASD-
bound PAHs induce their aggravating effects. The results
of the current study suggest that exposure to ASD with
Tar is a significant risk factor for adult and childhood
asthma. Atmospheric exposure to PAHs originating from
the combustion of organic matters and desert-dust may
influence human respiratory health on a world-wide scale.
Abbreviation
OVA: Ovalbumin; ASD: Asian sand dust; BALF: Bronchoalveolar lavage fluid;
PAHs: Polycyclic aromatic hydrocarbons; ELISA: Enzyme-linked
immunosorbent assays; EMSA: Electrophoretic mobility shift assay; H-
ASD: Heated Asian sand dust; IFN-γ: Interferon-γ; IL: Interleukin;
KC: Keratinocyte chemoattractant; MCP-1: Monocyte chemotactic protein-1;
MCP-3: Monocyte chemotactic protein-3; MIP-1α: Macrophage inflammatory
protein-1α; RANTES: Regulated on activation normal T cell expressed and
presumably secreted; TGF-β: Transforming growth factor-β.
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